Jazz Pharmaceuticals plc

Healthcare · Biotechnology · Ireland

Last price 207.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.49B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic ...